Literature DB >> 28626260

A case of API2-MALT1-positive gastric MALT lymphoma with concomitant diffuse large B-cell lymphoma.

Akashi Fujita1, Masahiro Tajika2, Tsutomu Tanaka2, Makoto Ishihara2, Yutaka Hirayama2, Nobumasa Mizuno1, Kazuo Hara1, Susumu Hijioka1, Hiroshi Imaoka1, Tsukasa Yoshida1, Nozomi Okuno1, Nobuhiro Hieda1, Takashi Hirayama1, Hitoshi Shibuya1, Hisashi Kondo1, Hirotaka Suzuki1, Kazuhiro Toriyama1, Yasushi Yatabe3, Kenji Yamao1, Yasumasa Niwa2.   

Abstract

API2-MALT1 translocation-positive gastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) lymphoma is thought to transform to diffuse large B-cell lymphoma (DLBCL) rarely. A 69-year-old man presented with epigastralgia. Esophagogastroduodenoscopy showed multiple ulcerations in the stomach. Endoscopic biopsies revealed MALT lymphoma, with Helicobacter pylori infection. The patient underwent eradication therapy with no improvement, and was thereafter followed without additional therapy at his request. Twelve years after initial diagnosis, follow-up computed tomography (CT) showed multiple nodules in bilateral lungs, and a needle biopsy revealed MALT lymphoma, the same as in the stomach and API2-MALT1 translocation was found. Because he again refused additional therapy, follow-up was continued. 15 years after initial diagnosis, CT showed lymphadenopathy at the splenic hilum. At first we suspected disease progression of gastric MALT lymphoma, however a needle biopsy revealed DLBCL without API2-MALT1. Thus, the tumor at the splenic hilum was finally diagnosed as a de novo DLBCL as a second malignancy. Although treatment with rituximab given his age and his wishes was attempted, he died of DLBCL 15 years after the initial diagnosis. We experienced an API2-MALT1-positive gastric MALT lymphoma with concomitant DLBCL, not transformed to DLBCL over a 15-year clinical course.

Entities:  

Keywords:  API2-MALT1; DLBCL; MALT lymphoma; Second malignancy

Mesh:

Substances:

Year:  2017        PMID: 28626260      PMCID: PMC5472550          DOI: 10.18999/nagjms.79.2.251

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  22 in total

1.  Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  E Zucca; M Dreyling
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways.

Authors:  Petr Starostik; Jochen Patzner; Axel Greiner; Stephan Schwarz; Jörg Kalla; German Ott; Hans Konrad Müller-Hermelink
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

3.  Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.

Authors:  Thomas Wündisch; Christian Thiede; Andrea Morgner; Astrid Dempfle; Annette Günther; Hongxiang Liu; Hongtao Ye; Ming-Qing Du; Theo D Kim; Ekkehard Bayerdörffer; Manfred Stolte; Andreas Neubauer
Journal:  J Clin Oncol       Date:  2005-10-03       Impact factor: 44.544

4.  EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.

Authors:  A Ruskoné-Fourmestraux; W Fischbach; B M P Aleman; H Boot; M Q Du; F Megraud; C Montalban; M Raderer; A Savio; A Wotherspoon
Journal:  Gut       Date:  2011-02-11       Impact factor: 23.059

5.  The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.

Authors:  G Ott; T Katzenberger; A Greiner; J Kalla; A Rosenwald; U Heinrich; M M Ott; H K Müller-Hermelink
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

6.  The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas.

Authors:  J Dierlamm; M Baens; I Wlodarska; M Stefanova-Ouzounova; J M Hernandez; D K Hossfeld; C De Wolf-Peeters; A Hagemeijer; H Van den Berghe; P Marynen
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

7.  Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years.

Authors:  Thomas Wündisch; Philipp Dieckhoff; Brandon Greene; Christian Thiede; Christian Wilhelm; Manfred Stolte; Andreas Neubauer
Journal:  Gastroenterology       Date:  2012-06-27       Impact factor: 22.682

8.  Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.

Authors:  Shotaro Nakamura; Toshiro Sugiyama; Takayuki Matsumoto; Katsunori Iijima; Shouko Ono; Masahiro Tajika; Akira Tari; Yasuhiko Kitadai; Hiroshi Matsumoto; Tadanobu Nagaya; Toshiro Kamoshida; Norihiko Watanabe; Toshimi Chiba; Hideki Origasa; Masahiro Asaka
Journal:  Gut       Date:  2011-09-02       Impact factor: 23.059

9.  Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approach.

Authors:  Barbara Bernasconi; Eva Karamitopoulou-Diamantis; Eva Karamitopolou-Diamantiis; Luigi Tornillo; Alessandro Lugli; Dolores Di Vizio; Stephan Dirnhofer; Stephan Wengmann; Katharyna Glatz-Krieger; Falko Fend; Carlo Capella; Luigi Insabato; Luigi M Terracciano
Journal:  Hum Pathol       Date:  2008-01-30       Impact factor: 3.466

10.  Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas.

Authors:  Sonia Toracchio; Hiroyoshi Ota; Daphne de Jong; Andrew Wotherspoon; Massimo Rugge; David Y Graham; Amir Samani; Hala M T El-Zimaity
Journal:  Cancer Sci       Date:  2009-03-23       Impact factor: 6.716

View more
  1 in total

Review 1.  Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature.

Authors:  Vadim Romanovich Gorodetskiy; Natalya Alexandrovna Probatova; Stefka Gospodinova Radenska-Lopovok; Natalya Valerievna Ryzhikova; Yulia Vladimirovna Sidorova; Andrey Borisovich Sudarikov
Journal:  Rheumatol Int       Date:  2019-11-09       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.